University of Palermo
Palermo, Sicily, 90133, Italy
NCT Number: NCT05318170
Although several studies have demonstrated the overall benefits of a laparoscopic approach for pelvic and para-aortic lymphadenectomy, complications remain a challenging scenario. Vascular injury occurs in 0.3% to 1.0% of laparoscopic procedures, with potentially lethal consequences. Vascular injuries are usually managed using coagulation, clamps or vascular sutures, but if these measures fail, laparotomy is inevitable.
To date, few reports evaluated the use of minimally invasive surgery for lymph node debulking in gynecological cancer patients with metastatic bulky lymph nodes, with encouraging results, despite the small sample sizes. Nevertheless, new minimally invasive surgery techniques that may minimize intraoperative complications are necessary. Considering these elements, this multicenter retrospective analysis is aimed to evaluate intra- and post-operative surgical outcomes, after laparoscopic ultraradical lymph nodal debulking using Yasargil clamps in gynecological cancer patients with bulky lymph node metastases.
Looking for future studies?
Notify Me18 year–80 year
Female
Observational
Palermo, Sicily, 90133, Italy
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Laparoscopic ultra-radical lymph node debulking using Yasargil clamps
Time frame: During the surgery and within 30 days after the surgery
Any complication occurred
Looking for future studies?
Notify MeUniversity of Palermo
Other
Evaluation of Surgical Outcomes After Laparoscopic Ultra-radical Lymph Node Debulking Using Yasargil Clamps for Gynecological Malignancies
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04945187
Adnexal Diseases, Endocrine Gland Neoplasms
Copenhagen, Denmark
View Trial DetailsNCT03425565
Advanced Cancer, Clear Cell Tumor
Edinburgh, United Kingdom
View Trial DetailsNCT05971303
Gynecologic Cancer
Toronto, Ontario, Canada
View Trial DetailsNCT07408349
Gynecologic Cancer
Ankara, Turkey (Türkiye)
View Trial Details